Alpha Teknova (TKNO) Total Current Liabilities (2020 - 2026)
Alpha Teknova's (TKNO) quarterly Total Current Liabilities came in at $6.9 million in Q1 2026, down 2.11% year-on-year from $7.0 million in Q1 2025, and down 8.5% on a QoQ basis from $7.5 million in Q4 2025.
Alpha Teknova (TKNO) Total Current Liabilities (2020 - 2026) Analysis & Trends
Alpha Teknova (TKNO) has 7 years of Total Current Liabilities data on file, last reported at $6.9 million in Q1 2026.
- On a quarterly basis, Total Current Liabilities fell 2.11% year-over-year to $6.9 million in Q1 2026; TTM through Mar 2026 was $6.9 million, a 2.11% decrease from a year earlier, with the FY2025 full-year figure at $7.5 million, down 32.77% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $6.9 million, down from $7.5 million in the prior quarter.
- Over the last five years, Total Current Liabilities for TKNO reached as high as $28.7 million in Q2 2023 and fell as low as $6.5 million in Q2 2025.
- Historically, Total Current Liabilities has averaged $10.1 million across 5 years, with a median of $8.7 million in 2023.
- Across the five-year window, Total Current Liabilities soared 141.48% in 2023 and slumped 74.13% in 2024, its largest moves.
- Year by year, Total Current Liabilities stood at $10.9 million in 2022, then declined by 18.39% to $8.9 million in 2023, then climbed by 26.32% to $11.2 million in 2024, then plunged by 32.77% to $7.5 million in 2025, then slipped by 8.5% to $6.9 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $6.9 million in Q1 2026, $7.5 million in Q4 2025, and $6.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.56 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.53 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 18.06 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 6.81 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 831.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.66 Bn |
| 10 | Alpha Teknova | 278.75 Mn | 260.97 Mn | 3.78 Mn | 6.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.90 Mn |
| Dec 31, 2025 | 7.54 Mn |
| Sep 30, 2025 | 6.94 Mn |
| Jun 30, 2025 | 6.48 Mn |
| Mar 31, 2025 | 7.05 Mn |
| Dec 31, 2024 | 11.21 Mn |
| Sep 30, 2024 | 9.72 Mn |
| Jun 30, 2024 | 7.41 Mn |
| Mar 31, 2024 | 7.04 Mn |
| Dec 31, 2023 | 8.88 Mn |
| Sep 30, 2023 | 8.34 Mn |
| Jun 30, 2023 | 28.65 Mn |
| Mar 31, 2023 | 8.65 Mn |
| Dec 31, 2022 | 10.88 Mn |
| Sep 30, 2022 | 12.33 Mn |
| Jun 30, 2022 | 11.87 Mn |
| Mar 31, 2022 | 12.64 Mn |
| Dec 31, 2021 | 7.74 Mn |
| Sep 30, 2021 | 6.20 Mn |
| Jun 30, 2021 | 5.94 Mn |